EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL — RANK Interaction

Titi Liu, Jin Li, Meiyan Duan, Ya Wang, Zhe Jiang, Chunxia Gan, Zemin Xiang, Jun Sheng, Xuanjun Wang, Huanhuan Xu iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Titi Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Science, Yunnan Agricultural University, Kunming, China. Hauptthemen laut MEDLINE: RANK Ligand, Osteoporosis, Osteogenesis, Osteoclasts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, People's Government of Yunnan Province, Natural Science Foundation of Yunnan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interaction between the receptor activator of nuclear factor‐κB ligand (RANKL) and its receptor RANK is known to regulate osteoclastogenesis in bone remodelling and has become an important therapeutic target for the treatment of osteoporosis. Stephanine (SA), an isoquinoline aporphine‐type alkaloid isolated from Stephania plants, possesses excellent anti‐inflammatory effects and can be used for rheumatoid arthritis treatment. However, its specific role in osteoclastogenesis and osteoporosis remains unknown. In this study, we investigated the influence of SA on osteoclastogenesis in RANKL‐stimulated RAW 264.7 cells and osteoporosis in an ovariectomised (OVX) mouse model and elucidated the underlying molecular mechanism. In vitro, SA can bind to RANK and RANKL with the K D values of 3.7 and 76.47 μM, respectively, and disrupt the RANKL–RANK interaction, which inhibits RANKL‐stimulated RANK–tumour necrosis factor receptor associated factor 6 (TRAF6) binding and RANK signalling pathways activation, downregulates the expression of key osteoclastogenesis‐related regulatory factors in osteoclast precursors, ultimately suppresses osteoclast differentiation and activation. In vivo, SA significantly ameliorated bone loss through inhibiting osteoclastogenesis in OVX mice because of the decreased number of osteoclasts and the increased trabecular bone area. SA markedly inhibited the serum levels of tartrate‐resistant acid phosphatase 5b (TRACP‐5b), c‐telopeptide of type I collagen (CTX‐I), and RANKL, whereas it increased that of osteoprotegerin (OPG) in OVX mice. Additionally, SA strikingly downregulated the OVX‐induced expression of osteoclast‐specific genes and proteins. Taken together, this study elucidated that SA can effectively protect against osteoporosis by suppressing osteoclastogenesis via inhibition of the RANKL–RANK interaction, which supports the potential application of SA as a natural therapeutic agent for osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RANK LigandOsteoporosisOsteogenesisOsteoclastsReceptor Activator of Nuclear Factor-kappa BCell DifferentiationAnimalsMiceRAW 264.7 CellsFemaleSignal TransductionTNF Receptor-Associated Factor 6OvariectomyAporphinesProtein BindingDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

RANK signallingRANKL–RANK interactionStephanineosteoclastogenesisosteoporosis

Substanzen

RANK LigandReceptor Activator of Nuclear Factor-kappa BTNF Receptor-Associated Factor 6AporphinesTnfsf11 protein, mouse

Autor:innen und Institutionen

  • College of Science, Yunnan Agricultural University, Kunming, China.
  • Key Laboratory of Pu-Er Tea Science, Ministry of Education, Yunnan Agricultural University, Kunming, China.
  • College of Food Science and Technology, Yunnan Agricultural University, Kunming, China.

ORCID-Profile: Huanhuan Xu

Förderung

  • National Natural Science Foundation of China
  • People's Government of Yunnan Province
  • Natural Science Foundation of Yunnan Province

Zitieren

APA

Liu, T., Li, J., Duan, M., Wang, Y., Jiang, Z., Gan, C., Xiang, Z., Sheng, J., Wang, X., & Xu, H. (2024). Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL — RANK Interaction. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70256

Vancouver

Liu T, Li J, Duan M, Wang Y, Jiang Z, Gan C, et al. Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL — RANK Interaction. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70256

BibTeX
@article{Liu2024,
  author = {Liu, Titi and Li, Jin and Duan, Meiyan and Wang, Ya and Jiang, Zhe and Gan, Chunxia and Xiang, Zemin and Sheng, Jun and Wang, Xuanjun and Xu, Huanhuan},
  title = {Stephanine Protects Against Osteoporosis by Suppressing Osteoclastogenesis via Inhibition of the RANKL — RANK Interaction},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70256}
}
Kostenlos starten →